News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Sharad Ghamande, MD

Articles by Sharad Ghamande, MD

Dr. Ghamande on the AIM2CERV Trial in Cervical Cancer

BySharad Ghamande, MD

January 12th 2018

Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the AIM2CERV trial for patients with cervical cancer.

Dr. Ghamande Discusses GOG/NRG 0265 Study in Cervical Cancer

BySharad Ghamande, MD

November 8th 2017

Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the GOG/NRG-0265 study in cervical cancer.

Latest Updated Articles

Dr. Ghamande Discusses GOG/NRG 0265 Study in Cervical Cancer
November 8th 2017
Dr. Ghamande on the AIM2CERV Trial in Cervical Cancer
January 12th 2018

Trending on OncLive

SERENA-6 Controversies Push the Breast Cancer Field to Consider the Future Role of ctDNA-Guided Treatment Decisions

FDA Approval Positions Belzutifan Plus Pembrolizumab as a New Adjuvant Standard in ccRCC

SYNC-T SV-102 Employs Novel Mechanism to Target Immunologically ‘Cold’ Tumors in Advanced Metastatic Prostate Cancer

Zanubrutinib Plus R-BAP Elicits High Response Rates in Treatment-Naive Mantle Cell Lymphoma

Surgeons, Medical Oncologists, and Radiation Oncologists Debate Current Thresholds for Systemic Therapy in EGFR-Mutated NSCLC